Ryuichi Harada

4.6k total citations
94 papers, 2.8k citations indexed

About

Ryuichi Harada is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ryuichi Harada has authored 94 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Physiology, 23 papers in Molecular Biology and 22 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ryuichi Harada's work include Alzheimer's disease research and treatments (44 papers), Neuroscience and Neuropharmacology Research (19 papers) and Dementia and Cognitive Impairment Research (14 papers). Ryuichi Harada is often cited by papers focused on Alzheimer's disease research and treatments (44 papers), Neuroscience and Neuropharmacology Research (19 papers) and Dementia and Cognitive Impairment Research (14 papers). Ryuichi Harada collaborates with scholars based in Japan, Australia and Canada. Ryuichi Harada's co-authors include Nobuyuki Okamura, Kazuhiko Yanai, Yukitsuka Kudo, Shozo Furumoto, Hiroyuki Arai, Takeo Yoshikawa, Victor L. Villemagne, Tetsuro Tago, Ren Iwata and Tadaho Nakamura and has published in prestigious journals such as PLoS ONE, Brain and Scientific Reports.

In The Last Decade

Ryuichi Harada

89 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryuichi Harada Japan 31 1.7k 754 669 563 552 94 2.8k
Johannes Streffer Belgium 30 1.6k 1.0× 491 0.7× 1.1k 1.7× 461 0.8× 536 1.0× 77 3.4k
Henry Engler Uruguay 25 1.7k 1.0× 1.2k 1.6× 479 0.7× 492 0.9× 367 0.7× 73 3.1k
Liying Han China 21 1.4k 0.8× 420 0.6× 943 1.4× 256 0.5× 540 1.0× 51 3.2k
Robert A. Comley United States 22 628 0.4× 272 0.4× 477 0.7× 293 0.5× 555 1.0× 48 1.8k
Claire E. Shepherd Australia 25 1.3k 0.8× 402 0.5× 802 1.2× 752 1.3× 369 0.7× 68 2.5k
Shu-fei Lin United States 33 640 0.4× 534 0.7× 947 1.4× 254 0.5× 1.3k 2.4× 83 3.3k
Zsolt Cselényi Sweden 24 543 0.3× 356 0.5× 380 0.6× 329 0.6× 444 0.8× 56 1.8k
Susanne Ostrowitzki Switzerland 18 985 0.6× 320 0.4× 456 0.7× 464 0.8× 352 0.6× 41 2.1k
Meixiang Yu United States 19 677 0.4× 515 0.7× 429 0.6× 274 0.5× 475 0.9× 46 1.8k
Joanne Norton United States 21 1.4k 0.8× 545 0.7× 703 1.1× 1.0k 1.8× 244 0.4× 40 2.6k

Countries citing papers authored by Ryuichi Harada

Since Specialization
Citations

This map shows the geographic impact of Ryuichi Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichi Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichi Harada more than expected).

Fields of papers citing papers by Ryuichi Harada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuichi Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichi Harada. The network helps show where Ryuichi Harada may publish in the future.

Co-authorship network of co-authors of Ryuichi Harada

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuichi Harada. A scholar is included among the top collaborators of Ryuichi Harada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuichi Harada. Ryuichi Harada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yokoyama, Yuka, Ryuichi Harada, Ren Iwata, et al.. (2024). Transmembrane protein 106B amyloid is a potential off-target molecule of tau PET tracers in the choroid plexus. Nuclear Medicine and Biology. 142-143. 108986–108986. 1 indexed citations
2.
Kobayashi, Ryota, Tadaho Nakamura, Fumito Naganuma, et al.. (2023). In vivo [18F]THK-5351 imaging detected reactive astrogliosis in argyrophilic grain disease with comorbid pathology: A clinicopathological study. Journal of Neuropathology & Experimental Neurology. 82(5). 427–437. 2 indexed citations
3.
Harada, Ryuichi, Yuka Yokoyama, Aiko Ishiki, et al.. (2023). Validation of A Novel MAO‐B PET tracer [18F]SMBT‐1 on postmortem human brain samples. Alzheimer s & Dementia. 19(S17). 1 indexed citations
4.
Matsuzawa, Takuro, Takeo Yoshikawa, Tomomitsu Iida, et al.. (2018). Heparan sulfate in pancreatic β-cells contributes to normal glucose homeostasis by regulating insulin secretion. Biochemical and Biophysical Research Communications. 499(3). 688–695. 8 indexed citations
5.
Ng, Kok Pin, Tharick A. Pascoal, Sulantha Mathotaarachchi, et al.. (2017). Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain. Alzheimer s Research & Therapy. 9(1). 25–25. 248 indexed citations
6.
Lockhart, Samuel N., Suzanne L. Baker, Nobuyuki Okamura, et al.. (2016). Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F] THK-5351. PLoS ONE. 11(6). e0158460–e0158460. 75 indexed citations
7.
Harada, Ryuichi, Shozo Furumoto, Tetsuro Tago, et al.. (2016). Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351. European Journal of Nuclear Medicine and Molecular Imaging. 43(12). 2211–2218. 18 indexed citations
8.
Okamura, Nobuyuki, Ryuichi Harada, Yukitsuka Kudo, & Kazuhiko Yanai. (2015). Amyloid and tau imaging, its present and future. Folia Pharmacologica Japonica. 146(3). 144–149. 1 indexed citations
9.
Li, Yi, Wai Tsui, Henry Rusinek, et al.. (2015). Cortical Laminar Binding of PET Amyloid and Tau Tracers in Alzheimer Disease. Journal of Nuclear Medicine. 56(2). 270–273. 22 indexed citations
10.
Mohsen, Attayeb, Takeo Yoshikawa, Tadaho Nakamura, et al.. (2014). Mechanism of the histamine H3 receptor-mediated increase in exploratory locomotor activity and anxiety-like behaviours in mice. Neuropharmacology. 81. 188–194. 23 indexed citations
11.
Yoshikawa, Takeo, Tadaho Nakamura, Tetsuro Shibakusa, et al.. (2014). Insufficient Intake of L-Histidine Reduces Brain Histamine and Causes Anxiety-Like Behaviors in Male Mice. Journal of Nutrition. 144(10). 1637–1641. 65 indexed citations
12.
Okamura, Nobuyuki, Ryuichi Harada, Shozo Furumoto, et al.. (2014). Tau PET Imaging in Alzheimer’s Disease. Current Neurology and Neuroscience Reports. 14(11). 500–500. 120 indexed citations
13.
Harada, Ryuichi, Nobuyuki Okamura, Shozo Furumoto, et al.. (2013). Comparison of the Binding Properties of Tau PET Radiotracer 18F-THK523 and Other Amyloid PET Tracers to Alzheimer's Disease Pathology. 2012. 132–135. 1 indexed citations
14.
Harada, Ryuichi, Nobuyuki Okamura, Shozo Furumoto, et al.. (2012). Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer’s disease pathology. European Journal of Nuclear Medicine and Molecular Imaging. 40(1). 125–132. 86 indexed citations
15.
Kim, Jihoon, Ryuichi Harada, Masaki Kobayashi, Natsuki Kobayashi, & Koji Sode. (2010). The inhibitory effect of pyrroloquinoline quinone on the amyloid formation and cytotoxicity of truncated alpha-synuclein. Molecular Neurodegeneration. 5(1). 20–20. 35 indexed citations
16.
Tsukakoshi, Kaori, Ryuichi Harada, Koji Sode, & Kazunori Ikebukuro. (2010). Screening of DNA aptamer which binds to α-synuclein. Biotechnology Letters. 32(5). 643–648. 38 indexed citations
17.
Harada, Ryuichi, Natsuki Kobayashi, Jihoon Kim, et al.. (2009). The effect of amino acid substitution in the imperfect repeat sequences of α-synuclein on fibrillation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1792(10). 998–1003. 21 indexed citations
18.
Tanaka, Makoto, et al.. (1995). Surgical Management of Postoperative Lymph Node Recurrence of Primary Lung Cancer.. Haigan. 35(2). 115–119.
19.
Sakao, Yukinori, et al.. (1995). Calcified Lymph Node Metastases in Bronchial Gland Cell Type Adenocarcinoma of The Lung.. Haigan. 35(1). 93–98. 1 indexed citations
20.
Hata, Eiji, et al.. (1994). [The necessity of extended systemic dissection of the regional lymph node in radical operation for lung cancer].. PubMed. 47(1). 40–4. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes Streffer Breakdown of academic impact, for papers by Henry Engler Breakdown of academic impact, for papers by Liying Han Breakdown of academic impact, for papers by Robert A. Comley Breakdown of academic impact, for papers by Claire E. Shepherd Breakdown of academic impact, for papers by Shu-fei Lin Breakdown of academic impact, for papers by Zsolt Cselényi Breakdown of academic impact, for papers by Susanne Ostrowitzki Breakdown of academic impact, for papers by Meixiang Yu Breakdown of academic impact, for papers by Joanne Norton
Rankless by CCL
2026